Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Temin

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapyVicki Leigh Keedy, Sarah Temin, Mark R Somerfield, et al.
Journal of Oncology Practice|January 2, 2013
Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinionRobert K Nam, Thomas K Oliver, Andrew J Vickers, et al.
Journal of Global Oncology|November 3, 2017
Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice GuidelineJose Jeronimo, Philip E Castle, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused updateHarold J Burstein, Sarah Temin, Holly Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancerCatherine H Van Poznak, Sarah Temin, Gary C Yee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline UpdateBetty R Ferrell, Jennifer S Temel, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateGregory A Masters, Sarah Temin, Christopher G Azzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline UpdateSharon H Giordano, Maria Alice B Franzoi, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline UpdateNaren Ramakrishna, Carey K Anders, Nancy U Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline UpdateNaren Ramakrishna, Sarah Temin, Sarat Chandarlapaty, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapyVicki Leigh Keedy, Sarah Temin, Mark R Somerfield, et al.
Journal of Oncology Practice|January 2, 2013
Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinionRobert K Nam, Thomas K Oliver, Andrew J Vickers, et al.
Journal of Global Oncology|November 3, 2017
Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice GuidelineJose Jeronimo, Philip E Castle, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused updateHarold J Burstein, Sarah Temin, Holly Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancerCatherine H Van Poznak, Sarah Temin, Gary C Yee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline UpdateBetty R Ferrell, Jennifer S Temel, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateGregory A Masters, Sarah Temin, Christopher G Azzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline UpdateSharon H Giordano, Maria Alice B Franzoi, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline UpdateNaren Ramakrishna, Carey K Anders, Nancy U Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline UpdateNaren Ramakrishna, Sarah Temin, Sarat Chandarlapaty, et al.
Pageof 8